Lingonberries reduce atherosclerosis in Apoe-/- mice in association with altered gut microbiota composition and improved lipid profile

Molecular Nutrition and Food Research

Volumn 60, Issue 5, 2016, Pages 1150-1160

  Matziouridou, Chrysoula ^a   Marungruang, Nittaya ^a   Nguyen, Thao Duy ^a   Nyman, Margareta ^a   Fåk, Frida ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Atherosclerosis; Gut microbiota; Lingonberries; Short chain fatty acids

Indexed keywords

CELL RECEPTOR; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CYP7A1 PROTEIN, MOUSE; NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 2; PLANT MEDICINAL PRODUCT; RNA 16S; STEROID 12ALPHA MONOOXYGENASE; TRIACYLGLYCEROL; VOLATILE FATTY ACID;

ADMINISTRATION AND DOSAGE; ANIMAL; APOLIPOPROTEIN E KNOCKOUT MOUSE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BACTEROIDETES; BLOOD; CECUM; CHEMISTRY; CLOSTRIDIUM; DIETARY FIBER; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INTESTINE FLORA; ISOLATION AND PURIFICATION; LINGONBERRY; LIPID DIET; LIPID METABOLISM; LIVER; LOW FAT DIET; MALE; METABOLISM; MICROBIOLOGY; MOUSE; ORGAN SIZE;

ANIMALS; ATHEROSCLEROSIS; BACTEROIDETES; CECUM; CHOLESTEROL; CHOLESTEROL 7-ALPHA-HYDROXYLASE; CLOSTRIDIUM; DIET, FAT-RESTRICTED; DIET, HIGH-FAT; DIETARY FIBER; FATTY ACIDS, VOLATILE; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION REGULATION; LIPID METABOLISM; LIVER; MALE; MICE; MICE, KNOCKOUT, APOE; ORGAN SIZE; PLANT PREPARATIONS; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, RIBOSOMAL, 16S; STEROID 12-ALPHA-HYDROXYLASE; TRIGLYCERIDES; VACCINIUM VITIS-IDAEA;

EID: 84961901677     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500738     Document Type: Article

References (34)

1. Singh, R. B., Mengi, S. A., Xu, Y. J., Arneja, A. S. et al., Pathogenesis of atherosclerosis: a multifactorial process. Exp. Clin. Cardiol. 2002, 7, 40-53.
2. Wigren, M., Bjorkbacka, H., Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol. 2010, 21, 97-98.
3. Coleman, R., Hayek, T., Keidar, S., Aviram, M., A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice. Acta histochemica. 2006, 108, 415-424.
4. Fruchart, J. C., Nierman, M. C., Stroes, E. S., Kastelein, J. J. et al., New risk factors for atherosclerosis and patient risk assessment. Circulation. 2004, 109, III15-III19.
5. Szajdek, A., Borowska, E. J., Bioactive compounds and health-promoting properties of berry fruits: a review. Plant Food Hum. Nutri (Dordrecht, the Netherlands). 2008, 63, 147-156.
6. Plaami, S., Kumpulainen, J., Tahvonen, R., Total dietary fiber contents in vegetables, fruits and berries consumed in Finland. J Sci Food Agric. 1992, 59, 545-549.
7. Anhe, F. F., Roy, D., Pilon, G., Dudonne, S. et al., A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut. 2014, 64, 872-883.
8. Heyman, L., Axling, U., Blanco, N., Sterner, O. et al., Evaluation of beneficial metabolic effects of berries in high-fat fed C57BL/6J mice. J. Nutri. Metab. 2014, 2014, 403041.
9. Linderborg, K. M., Jarvinen, R., Lehtonen, H. M., Viitanen, M. et al., The fiber and/or polyphenols present in lingonberries null the glycemic effect of the sugars present in the berries when consumed together with added glucose in healthy human volunteers. Nutri. Res. (New York, NY). 2012, 32, 471-478.
10. Slyper, A. H., The influence of carbohydrate quality on cardiovascular disease, the metabolic syndrome, type 2 diabetes, and obesity - an overview. J. Pediatr. Endocrinol. Metab.: JPEM. 2013, 26, 617-629.
11. Slavin, J. L., Position of the American Dietetic Association: health implications of dietary fiber. J. Am. Diet Assoc. 2008, 108, 1716-1731.
12. Gallo, L. Cardiovascular Disease: Molecular and Cellular Mechanisms, Prevention, and Treatment. NYC: NYC:Plenum Press; 1987.
13. Anderson, J. W., Dietary fiber, lipids and atherosclerosis. Am. J. Cardiol. 1987, 60, 17G-22G.
14. Zhang, S. H., Reddick, R. L., Piedrahita, J. A., Maeda, N., Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258, 468-471.
15. Zaiou, M., Arnold, K. S., Newhouse, Y. M., Innerarity, T. L. et al., Apolipoprotein E;-low density lipoprotein receptor interaction. Influences of basic residue and amphipathic alpha-helix organization in the ligand. J Lipid Res. 2000, 41, 1087-1095.
16. Klindworth, A., Pruesse, E., Schweer, T., Peplies, J. et al., Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2013, 41, e1.
17. Caporaso, J., Kuczynski, J., Stombaugh, J., Bittinger, K. et al., QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010, 7, 335-6.
18. Zhao, G., Nyman, M., Jonsson, J. A., Rapid determination of short-chain fatty acids in colonic contents and faeces of humans and rats by acidified water-extraction and direct-injection gas chromatography. Biomed. Chromatogr.: BMC. 2006, 20, 674-682.
19. Asp, N. G., Johansson, C. G., Hallmer, H., Siljestrom, M., Rapid enzymatic assay of insoluble and soluble dietary fiber. J. Agri. Food Chem. 1983, 31, 476-482.
20. Theander, O., Aman, P., Westerlund, E., Andersson, R. et al., Total dietary fiber determined as neutral sugar residues, uronic acid residues, and Klason lignin (the Uppsala method): collaborative study. J. AOAC Int. 1995, 78, 1030-1044.
21. Segata, N., Izard, J., Waldron, L., Gevers, D. et al., Metagenomic biomarker discovery and explanation. Genome Biol. 2011, 12, R60.
22. Wang, S. Y., Feng, R., Bowman, L., Penhallegon, R. et al., Antioxidant activity in lingonberries (Vaccinium vitis-idaea L.) and its inhibitory effect on activator protein-1, nuclear factor-kappaB, and mitogen-activated protein kinases activation. J. Agri. Food Chem. 2005, 53, 3156-3166.
23. Niki, E., Antioxidants and atherosclerosis. Biochem. Soc. Trans. 2004, 32, 156-159.
24. Levrat, M. A., Favier, M. L., Moundras, C., Remesy, C. et al., Role of dietary propionic acid and bile acid excretion in the hypocholesterolemic effects of oligosaccharides in rats. J Nutr. 1994, 124, 531-538.
25. Fernandes, J., Su, W., Rahat-Rozenbloom, S., Wolever, T. M. et al., Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans. Nutr Diabetes. 2014, 4:e121.
26. Belland, R. J., Ouellette, S. P., Gieffers, J., Byrne, G. I., Chlamydia pneumoniae and atherosclerosis. Cell. Microbiol. 2004, 6, 117-127.
27. Stepankova, R., Tonar, Z., Bartova, J., Nedorost, L. et al., Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet. J Atheroscler Thromb. 2010;Apr 2 (Epub ahead of print).
28. Mencarelli, A., Cipriani, S., Renga, B., Bruno, A. et al., VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation. PLoS One. 2012, 7, e45425.
29. Cani, P., Bibiloni, R., Knauf, C., Waget, A. et al., Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008, 57, 1470-1481.
30. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P. et al., Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 2013, 110, 9066-9071.
31. Trindade, B. C., Theriot, C. M., Leslie, J. L., PE, C. Jr. et al., Clostridium difficile-induced colitis in mice is independent of leukotrienes. Anaerobe. 2014, 30, 90-98.
32. Mathew, O. P., Ranganna, K., Milton, S. G., Involvement of the antioxidant effect and anti-inflammatory response in butyrate-inhibited vascular smooth muscle cell proliferation. Pharmaceuticals (Basel, Switzerland). 2014, 7, 1008-1027.
33. Kong, B., Wang, L., Chiang, J. Y., Zhang, Y. et al., Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice. Hepatology. 2012, 56, 1034-1043.
34. Sayin, S. I., Wahlstrom, A., Felin, J., Jantti, S. et al., Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013, 17, 225-235.